The classification and diagnostic criteria of ankylosing spondylitis

Siba P Raychaudhuri, Atul Deodhar

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Ankylosing spondylitis is the prototype of immune-mediated inflammatory rheumatic diseases grouped under the term spondyloarthritis (SpA). An early diagnosis has now become increasingly important because effective therapies are available and anti-TNF drugs are even more effective if used in early stages of the disease. In ankylosing spondylitis, the 1984 modified New York criteria have been used widely in clinical studies and daily practice but are not applicable in early disease when the characteristic radiographic signs of sacroiliitis are not visible but active sacroiliitis is readily detectable by magnetic resonance imaging (MRI). Thus there has been a need for new classification or diagnostic criteria to identify inflammatory spondyloarthritis at early stage of the disease. This led to the concept of axial SpA to include the entire spectrum of patients with axial disease both, with and without radiographic damage. New classification criteria for the wider group of SpA have been proposed by ASAS (Assessment of Spondylo Arthritis International Society); and the patients are sub-grouped into (1) a predominantly axial disease, termed axial SpA including AS and non-radiographic axial SpA; (2) peripheral SpA. The clinical course and disease process of non-radiographic axial spondyloarthritis remains unclear. However the development of the SpA criteria by ASAS particularly for axial SpA, is an important step for early diagnosis and better management of these patients.

Original languageEnglish (US)
Pages (from-to)128-133
Number of pages6
JournalJournal of Autoimmunity
Volume48-49
DOIs
StatePublished - 2014

Fingerprint

Ankylosing Spondylitis
Sacroiliitis
Arthritis
Early Diagnosis
Rheumatic Diseases
Magnetic Resonance Imaging
Pharmaceutical Preparations

Keywords

  • Ankylosing spondylitis
  • Diagnosis
  • Diagnostic criteria
  • Spondyloarthropathy

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

The classification and diagnostic criteria of ankylosing spondylitis. / Raychaudhuri, Siba P; Deodhar, Atul.

In: Journal of Autoimmunity, Vol. 48-49, 2014, p. 128-133.

Research output: Contribution to journalArticle

@article{a720d83c3ae2451299ce5d63acf1052d,
title = "The classification and diagnostic criteria of ankylosing spondylitis",
abstract = "Ankylosing spondylitis is the prototype of immune-mediated inflammatory rheumatic diseases grouped under the term spondyloarthritis (SpA). An early diagnosis has now become increasingly important because effective therapies are available and anti-TNF drugs are even more effective if used in early stages of the disease. In ankylosing spondylitis, the 1984 modified New York criteria have been used widely in clinical studies and daily practice but are not applicable in early disease when the characteristic radiographic signs of sacroiliitis are not visible but active sacroiliitis is readily detectable by magnetic resonance imaging (MRI). Thus there has been a need for new classification or diagnostic criteria to identify inflammatory spondyloarthritis at early stage of the disease. This led to the concept of axial SpA to include the entire spectrum of patients with axial disease both, with and without radiographic damage. New classification criteria for the wider group of SpA have been proposed by ASAS (Assessment of Spondylo Arthritis International Society); and the patients are sub-grouped into (1) a predominantly axial disease, termed axial SpA including AS and non-radiographic axial SpA; (2) peripheral SpA. The clinical course and disease process of non-radiographic axial spondyloarthritis remains unclear. However the development of the SpA criteria by ASAS particularly for axial SpA, is an important step for early diagnosis and better management of these patients.",
keywords = "Ankylosing spondylitis, Diagnosis, Diagnostic criteria, Spondyloarthropathy",
author = "Raychaudhuri, {Siba P} and Atul Deodhar",
year = "2014",
doi = "10.1016/j.jaut.2014.01.015",
language = "English (US)",
volume = "48-49",
pages = "128--133",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - The classification and diagnostic criteria of ankylosing spondylitis

AU - Raychaudhuri, Siba P

AU - Deodhar, Atul

PY - 2014

Y1 - 2014

N2 - Ankylosing spondylitis is the prototype of immune-mediated inflammatory rheumatic diseases grouped under the term spondyloarthritis (SpA). An early diagnosis has now become increasingly important because effective therapies are available and anti-TNF drugs are even more effective if used in early stages of the disease. In ankylosing spondylitis, the 1984 modified New York criteria have been used widely in clinical studies and daily practice but are not applicable in early disease when the characteristic radiographic signs of sacroiliitis are not visible but active sacroiliitis is readily detectable by magnetic resonance imaging (MRI). Thus there has been a need for new classification or diagnostic criteria to identify inflammatory spondyloarthritis at early stage of the disease. This led to the concept of axial SpA to include the entire spectrum of patients with axial disease both, with and without radiographic damage. New classification criteria for the wider group of SpA have been proposed by ASAS (Assessment of Spondylo Arthritis International Society); and the patients are sub-grouped into (1) a predominantly axial disease, termed axial SpA including AS and non-radiographic axial SpA; (2) peripheral SpA. The clinical course and disease process of non-radiographic axial spondyloarthritis remains unclear. However the development of the SpA criteria by ASAS particularly for axial SpA, is an important step for early diagnosis and better management of these patients.

AB - Ankylosing spondylitis is the prototype of immune-mediated inflammatory rheumatic diseases grouped under the term spondyloarthritis (SpA). An early diagnosis has now become increasingly important because effective therapies are available and anti-TNF drugs are even more effective if used in early stages of the disease. In ankylosing spondylitis, the 1984 modified New York criteria have been used widely in clinical studies and daily practice but are not applicable in early disease when the characteristic radiographic signs of sacroiliitis are not visible but active sacroiliitis is readily detectable by magnetic resonance imaging (MRI). Thus there has been a need for new classification or diagnostic criteria to identify inflammatory spondyloarthritis at early stage of the disease. This led to the concept of axial SpA to include the entire spectrum of patients with axial disease both, with and without radiographic damage. New classification criteria for the wider group of SpA have been proposed by ASAS (Assessment of Spondylo Arthritis International Society); and the patients are sub-grouped into (1) a predominantly axial disease, termed axial SpA including AS and non-radiographic axial SpA; (2) peripheral SpA. The clinical course and disease process of non-radiographic axial spondyloarthritis remains unclear. However the development of the SpA criteria by ASAS particularly for axial SpA, is an important step for early diagnosis and better management of these patients.

KW - Ankylosing spondylitis

KW - Diagnosis

KW - Diagnostic criteria

KW - Spondyloarthropathy

UR - http://www.scopus.com/inward/record.url?scp=84895891538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895891538&partnerID=8YFLogxK

U2 - 10.1016/j.jaut.2014.01.015

DO - 10.1016/j.jaut.2014.01.015

M3 - Article

VL - 48-49

SP - 128

EP - 133

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

ER -